A Phase 1b, Randomized, Placebo-Controlled, Double-Blind Study to Assess the Pharmacokinetics, Safety and Efficacy of ARRY-371797 [ARRY-797] in Patients With Rheumatoid Arthritis (RA) Receiving Stable Doses of Methotrexate (MTX).

Trial Profile

A Phase 1b, Randomized, Placebo-Controlled, Double-Blind Study to Assess the Pharmacokinetics, Safety and Efficacy of ARRY-371797 [ARRY-797] in Patients With Rheumatoid Arthritis (RA) Receiving Stable Doses of Methotrexate (MTX).

Completed
Phase of Trial: Phase I

Latest Information Update: 23 Apr 2012

At a glance

  • Drugs ARRY 797 (Primary)
  • Indications Rheumatoid arthritis
  • Focus Adverse reactions; Biomarker; Pharmacokinetics; Therapeutic Use
  • Sponsors Array BioPharma
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 09 Jul 2009 Results reported in a Array BioPharma media release.
    • 01 May 2009 Actual end date (Apr 2009) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top